Novartis sues US government over Medicare drug price regulation
Published
Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure medicine Entresto. The lawsuit, filed in federal court in New Jersey, is the first since the Biden administration…
#medicare #entresto #newjersey #bristolmyerssquibb #pfizer #merck #eliquis #xarelto #johnsonjohnson #centersformedicare